Vivani Medical, Inc. will be presenting at the Emerging Growth Conference 86 on September 25, 2025. The company is a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants. Vivani President and CEO Adam Mendelsohn, Ph.D., will provide an overview of the company during the 30-minute presentation starting at 1:45 pm Eastern Time. The presentation aims to engage with individual and institutional investors, advisors, and analysts. Questions can be submitted in advance for discussion. Registration is required to attend the conference and receive updates. Vivani aims to improve patient adherence and tolerance to medication through its NanoPortal™ platform.

Read more at GlobeNewswire: Vivani Medical to Present at the Emerging Growth Conference